Summary
Radioligand binding studies were performed in membranes of rabbit whole brain and striatum using the novel iodinated radioligand for 5-hydroxytryptamine 5-HT1B and 5-HT1D sites, Serotonin-5-O-Carboxymethyl-Glycyl[125I]Tyrosinamide ([125I]GTI).
[125I]GTI labelled a finite number of high affinity sites in rabbit brain membranes, Bmax = 191 +- 47 fmol/mg protein, pKD (-log mol/1) = 8.50 +- 0.13, n = 5. The pharmacological profile of [152I]GTI binding was fully comparable to that reported previously in human and other brain preparations known to possess 5-HT1D sites (using either [3H]5-HT or [125I]GTI) and displayed a characteristic rank order of affinity: 5-carboxamidotryptamine > 5-HT = dihydroergotamine _> ergotamine ≥_ sumatriptan >_ CGS 12066 >- metergoline > yohimbine >_ methysergide > ICYP > 8-OH-DPAT >_ CP 93129 > (-)pindolol > ketanserin > isamoltane > mesulergine > corynanthine > buspirone > MDL 72222.
Autoradiographic studies were performed on rabbit brain slices using [3H]5-HT in the presence of 100 nmol/1 8-OH-DPAT and mesulergine (in order to mask 5-HT1A and 5-HT1c binding sites) and [125I]CYP (iodocyanopindolol) in the presence of β µmol/I isoprenaline and 100 nmol/l 8-OH-DPAT (in order to mask β adrenoceptor and 5-HT1A binding sites). There was no detectable specific binding of [125I]CYP through the brain, thus excluding the presence of 5-HT1B sites in rabbit brain. By contrast, [3H]5-HT labelled a high density of sites in globus pallidus, substantia nigra and superior colliculus. Other regions displaying labelling include the striatum, the dentate gyrus of the hippocampus and the periaqueductal grey matter. This pattern of distribution is compatible with that reported for 5-HT1D sites in other species.
The present data strongly suggest that rabbit brain has recognition sites with the pharmacological profile and distribution characteristic of the 5-HT1D recognition site. These findings are in agreement with results obtained by Limberger et al. (1991), suggesting the terminal 5-HT autoreceptor of the rabbit brain to belong to the 5-HT1D subtype. Except for limited species variations (see Bruinvels et al. 1992), the pharmacology of these sites does not justify an addition to the existing nomenclature (“5-HT1R”), in contrast to what has been proposed by Xiong and Nelson (1989). The rabbit represents another laboratory species in which 5-HT1D receptor mediated effects could be studied.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adham N, Romanienko P, Hartig P, Weinshank RL, Branchek T (1992) The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1Dβ receptor. Mol Pharmacol 41:1–7
Boulenguez P, Chauveau J, Segu L, Morel A, Lanoir J, Delaage M (1991a) A new 5-hydroxy-indole derivative with preferential affinity for 5-HT1B sites. Eur J Pharmacol 194:91–98
Boulenguez P, Chauveau J, Segu L, Morel A, Delaage M, Lanoir J (1991b) Pharmacological characterization of serotonin-O-carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT)1B and 5-HT1D binding sites. J Pharmacol Exp Ther 259:1360–1365
Boulenguez P, Segu L, Chauveau J, Morel A, Lanoir J, Delaage M (1992) Biochemical and pharmacological characterization of serotonin-O-carboxymethylglycyl[125I]iodotyrosinanude, a new radioiodinated probe for 5-HT1B and 5-HT1D binding sites. J Neurochem 58:951–959
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576
Branchek TA, Weinshank RL, Macchi MJ, Zgombick JM, Hartig PR (1991). The cloning of a human 5-HT1D receptor. In: Fozard JR, Saxena PR (eds) Serotonin: molecular biology, receptors and functional effects. Birkhäuser, Basel, pp 21–32
Bruinvels AT, Landwehrmeyer B, Waeber C, Palacios JM, Hoyer D (1991) Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand. Eur J Pharmacol 202:89–91
Bruinvels AT, Lery H, Nozulak J, Palacios JM, Hoyer D (1992) 5-HT1D binding sites in various species: similar pharmacological profile in calf, guinea-pig, dog, monkey and human brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 346:243–248
Hamblin MW, Metcalf MA (1991) Primary structure and functional characterization of a human 5-hydroxytryptamine1D type serotonin receptor. Mol Pharmacol 40:143–148
Hartig P (1989) Molecular biology of 5-HT receptors. Trends Pharmacol Sci 10:64–69
Hartig P, Kao HT, Macchi M, Adham N, Zgombick K, Weinshank R, Branchek T (1990) The molecular biology of serotonin receptors: An overview. Neuropsychopharmacology 3:335–347
Hartig PR, Branchek TA, Weinshank RL (1992) A subfamily of serotonin 5-HT1D receptor genes. Trends Pharmacol Sci 13: 152–159
Heuring RE, Peroutka SJ (1987) Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes. J Neurosci 7:894–903
Hoyer D (1988) Molecular pharmacology and biology of 5-HT1c receptors. Trends Pharmacol Sci 9:89–94
Hoyer D (1990) Serotonin 5-HT3, 5-HT4 and 5-HT-M receptors. Neuropharmacology 3:371–383
Hoyer D, Middlemiss DN (1989) The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: evidence for species differences. Trends Pharmacol Sci 10:130–132
Hoyer D, Engel G, Kalkman HO (1985a) Characterization of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol. Eur J Pharmacol 118:1–12
Hoyer D, Engel G, Kalkman HO (1985b) Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with 5-HT, 8-OH-DPAT, (−)[125]iodocyanopindolol, mesulergine and ketanserin. Eur J Pharmacol 118:13–23
Hoyer D, Pazos A, Probst A, Palacios JM (1986a) Serotonin receptors in the human brain I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res 376:85–96
Hoyer D, Pazos A, Probst A, Palacios JM (1986b) Serotonin receptors in the human brain II. Characterization and autoradiographic localization of 5-HT1c and 5-HT2 recognition sites. Brain Res 376:97–107
Hoyer D, Waeber C, Pazos A, Probst A, Palacios JM(1988) Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1c sites. Neurosci Lett 85:357–362
Julius D, MacDermott AB, Axel R, Jessell TM (1988) Molecular characterization of a functional cDNA encoding the serotonin 1c receptor. Science 241:558–564
Leonhardt S, Herrick-Davis K, Titeler M (1989) Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein. J Neurochem 53:465–471
Limberger N, Deicher R, Starke K (1991) Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343:353–364
Murphy TJ, Bylund DB (1989) Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. J Pharm Exp Ther 249:535–543
Palacios JM, Waeber C, Bruinvels AT, Hoyer D (1992) Direct visualization of serotonin1D receptors in the human brain using a new radioiodinated radioligand. Mol Brain Res 13:175–179
Pazos A, Hoyer D, Palacios JM (1984) Mesulergin, a selective serotonin-2 ligand in the rat cortex, does not label these receptors, in porcine and human cortex; Evidence for species differences on brain serotonin-2 receptors. Eur J Pharmacol 106:531–538
Pritchett DB, Bach AWJ, Wozny M, Taleb O, Dal Toso R, Shih JC, Seeburg PH (1988) Structure and functional expression of cloned rat serotonin 5-HT2 receptor. EMBO J 7:4135–4140
Schoeffter P, Waeber C, Palacios JM, Hoyer D (1988) The serotonin 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn-Schmiedeberg's Arch Pharmacol 337:602–608
Segu L, Chauveau J, Boulenguez P, Morel A, Lanoir J, Delaage M (1991) Synthesis and pharmacological study of a radioiodinated serotonin derivative specific for 5-HT1B and 5-HT1D binding sites of the central nervous system. C R Acad Sci Paris 312:655–661
Seuwen K, Magnaldo I, Pouysségur J (1988) Serotonin stimulates DNA synthesis in fibroblasts acting through 5-HT1B receptors coupled to a Gi-protein. Nature 335:254–256
Sumner MJ, Humphrey PPA (1989) 5-HT1D binding sites in porcine brain can be sub-divided by GR43175. Br J Pharmacol 98:29–31
Waeber C, Died MM, Hoyer D, Probst A, Palacios JM (1988a) Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography. Neurosci Lett 88:11–16
Wacber C, Schoeffter P, Palacios JM, Hoyer D (1988b) Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 337:595–601
Waeber C, Schoeffter P, Hoyer D, Palacios JM (1990) The serotonin 5-HT1D receptor: a progress review. Neurochem Res 15:567–582
Xiong W-C, Nelson DL (1989) Characterization of a 5-hydroxytryptamine binding site in rabbit caudate nucleus that differs from the 5-HT1A, 5-HT1B, 5-HT1c and 5-HT1D subtypes. Life Sci 45:1433–1442
Author information
Authors and Affiliations
Additional information
Correspondence to D. Hoyer at the above address
Rights and permissions
About this article
Cite this article
Hoyer, D., Lery, H., Waeber, C. et al. “5-HT1R” or 5-HT1D sites? Evidence for 5-HT 1D binding sites in rabbit brain. Naunyn-Schmiedeberg's Arch Pharmacol 346, 249–254 (1992). https://doi.org/10.1007/BF00173536
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00173536